SpaceX Is Crashing the Wireless Party. Telecom Stocks Are Paying the Price. -- Barrons.com
Dow Jones2026/10/08 21:53By Al Root SpaceX announced a wireless spectrum acquisition late Thursday, stoking fears of wireless telecom disruption and sending shares of AT&T and its peers lower. The agreement, with Grain Management, would give SpaceX a nationwide low-band spectrum license portfolio of up to 14 megahertz of paired spectrum in the 800 MHz band. "This prime low-band spectrum addresses one of the key remaining technical gaps that will pave the way for Starlink Mobile to become a major mobile carrier in the U.S.," said the company in a news release. That's competition for the traditional industry. AT&T stock was down 7% in after-hours trading. Verizon Communications and T-Mobile shares were both off about 6.6%. Shares of wireless infrastructure provider Crown Castle and American Tower, however, were up almost 9% and 6%, respectively. It appears that SpaceX needs terrestrial infrastructure, too. "Starlink Mobile's flexible, hybrid architecture will leverage both terrestrial and satellite technology to ensure all Americans have high-speed mobile broadband," reads part of the agreement. Grain Management has historical relationships with wireless tower providers. The deal is significant for the wireless industry. SpaceX isn't content to only offer broadband service. It appears to want to control the phone, too. Spectrum assets are becoming more valuable as space-based communications options proliferate. Spectrum is a finite resource. Just as two radio stations in an area can't broadcast on the same frequency, wireless data providers need their own spectrum to avoid running into one another. Comcast stock was down 1.9% in after-hours trading. Cable companies also offer wireless service, partly to offset losses in their broadband business to wireless companies that offer internet to the home. The wireless industry is changing -- with SpaceX at the heart of the disruption. Write to Al Root at allen.root@barrons.com. This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow
By Al Root
SpaceX announced a wireless spectrum acquisition late Thursday, stoking fears of wireless telecom disruption and sending shares of AT&T and its peers lower.
The agreement, with Grain Management, would give SpaceX a nationwide low-band spectrum license portfolio of up to 14 megahertz of paired spectrum in the 800 MHz band.
"This prime low-band spectrum addresses one of the key remaining technical gaps that will pave the way for Starlink Mobile to become a major mobile carrier in the U.S.," said the company in a news release.
That's competition for the traditional industry. AT&T stock was down 7% in after-hours trading. Verizon Communications and T-Mobile shares were both off about 6.6%.
Shares of wireless infrastructure provider Crown Castle and American Tower, however, were up almost 9% and 6%, respectively. It appears that SpaceX needs terrestrial infrastructure, too.
"Starlink Mobile's flexible, hybrid architecture will leverage both terrestrial and satellite technology to ensure all Americans have high-speed mobile broadband," reads part of the agreement.
Grain Management has historical relationships with wireless tower providers.
The deal is significant for the wireless industry. SpaceX isn't content to only offer broadband service. It appears to want to control the phone, too.
Spectrum assets are becoming more valuable as space-based communications options proliferate. Spectrum is a finite resource. Just as two radio stations in an area can't broadcast on the same frequency, wireless data providers need their own spectrum to avoid running into one another.
Comcast stock was down 1.9% in after-hours trading. Cable companies also offer wireless service, partly to offset losses in their broadband business to wireless companies that offer internet to the home.
The wireless industry is changing -- with SpaceX at the heart of the disruption.
Write to Al Root at allen.root@barrons.com.
This content was created by Barron's, which is operated by Dow Jones & Co. Barron's is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
October 08, 2026 17:53 ET (21:53 GMT)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Analyst Gu Jingci: Follow the trend and adapt flexibly
XRP Ledger adds account control feature, enabling enterprises to manage assets offline.
BUZZ - Goldman Sachs says the price cap on cancer drugs has limited impact on Indian hospitals
October 9 – Goldman Sachs pointed out that India's implementation of a 30% profit margin cap on non-scheduled anticancer drugs (link) will have limited impact on hospitals. The report states that, based on preliminary discussions with hospital chain groups, such drugs account for less than 5% of hospital revenue and 2% to 2.5% of operating profit. The report adds that hospitals can offset the losses by slightly adjusting service charges, such as administration fees. According to a government notice, an expert committee will finalize the list of drugs to be brought under regulation. Driven by the anticipated price cap, the share prices of Max Healthcare MAXE.NS, Apollo Hospitals APLH.NS, and Fortis Healthcare FOHE.NS rose by 1.6% to 2.5%. Previously, since September 30, these stocks had collectively declined by 11% to 11.5%. Year-to-date, FOHE and MAXE are down 11.7% and 14.8%, respectively, while APLH has risen by 11%. (To assist non-English speakers, Reuters provides automated translations of its reports into several other languages. Due to potential errors or missing context in automated translations, Reuters does not guarantee the accuracy of automatic translation texts and offers them solely for readers’ convenience. Reuters accepts no responsibility for any damage or loss caused by using these automated translation features.)
Adding insult to injury! Japanese electronics giant Nidec downgraded by UBS, stock price plunges over 9% and approaches an 11-month low
UBS has downgraded Nidec's rating from "Buy" to "Neutral" and lowered its target price from 2,800 yen to 2,400 yen, citing a more challenging market environment.
Crypto prices
More
